Klowden Michael
SEC insider (Form 3/4/5 filer). CIK 0001991117. Director at NKGen Biotech, Inc. (NKGN). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 6, 2024. Located in SANTA ANA, CA.
Companies Klowden Michael has filed insider reports for
- NKGen Biotech, Inc. (NKGN): Director
Klowden Michael
CIK: 0001991117
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NKGN
NKGen Biotech, Inc.
Director